The Zenith TX2 TAA Endovascular stent graft is designed as a two-piece modular system, although implantation of a single device may be sufficient for focal thoracic aortic lesions (see fig 8).

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2024 financial results will be released on ...

Bentley InnoMed GmbH announced the launch of the BeGraft stent graft system, an on-label bridging device for fenestrated endova ...

This is an emergency, Conner said. About 50% of people who have an aortic dissection die at home. Of the other 50% who make ...

Aneurysm occurs when a blood vessel weakens and bulges If this blood vessel is ruptured it can lead to severe internal ...

Christian Medical College inaugurates a state-of-the-art vascular surgery hybrid theatre, offering cutting-edge operations ...

Meanwhile, Endospan has completed enrolment in the primary arm of a clinical trial evaluating its stent graft for the treatment of aortic arch disease. "Alleviant Medical secures $90m to launch ...

Exchange Traded Concepts LLC lessened its stake in shares of Artivion, Inc. (NYSE:AORT – Free Report) by 16.6% in the fourth ...

Artivion (NYSE:AORT – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at Needham & Company ...